What did @_life_with_kaitlyn actually say?
She made a specific, practical claim: compounded semaglutide lets you titrate in smaller increments than branded Ozempic or Wegovy, and slower titration is generally better if you're still seeing results at lower doses. She walked through her own schedule, going from 0.25 mg up to 0.75 mg in gradual steps, and argued this gave her appetite suppression without having to "double" her dose the way a branded pen would require.
To be clear about what she said and didn't say: she wasn't claiming compound semaglutide is equivalent to Ozempic or Wegovy. She was making a flexibility argument. She also mentioned doing "research" to support the slower-is-better approach, though she didn't cite any specific studies. That's worth scrutinizing.
Does the science back this up?
Partly, yes. The slow-titration logic is real, and the flexibility claim about compounded formulations is accurate in practice, but it comes with serious caveats she glossed over.
Wegovy's approved titration schedule starts at 0.25 mg weekly for four weeks, then steps up in 0.25 mg increments every four weeks until reaching a 2.4 mg maintenance dose. Ozempic follows a similar staircase. These aren't arbitrary, they reflect what Novo Nordisk tested for tolerability in the STEP trials (Wilding et al., 2021, New England Journal of Medicine), where GI side effects were the primary reason patients dropped out or reduced doses. The slow ramp was engineered to reduce nausea, vomiting, and diarrhea.
So the underlying idea, that titrating slowly can improve tolerability, is supported by the clinical rationale behind FDA-approved schedules. What isn't supported by controlled data is the idea that going even slower than approved schedules produces better weight loss outcomes. We simply don't have that trial.
What did they get wrong (or right)?
She got the general principle right but overstated the freedom compounding offers without flagging the risks.
On the right side: it's accurate that compounded semaglutide from a 503A or 503B pharmacy can be prepared in non-standard concentrations, which does allow doses that don't exist in branded pen format. Clinicians prescribing compounded versions do have more flexibility on paper.
On the wrong side: she says "there's no reason to go to higher doses" if you're seeing progress at lower ones. That's not quite right. The STEP 1 trial showed dose-dependent weight loss, with the 2.4 mg dose achieving roughly 15 percent body weight reduction versus meaningfully less at sub-therapeutic doses. Staying low indefinitely because you feel okay isn't necessarily the same as optimizing outcomes. That's a conversation to have with a prescribing clinician, not a decision to make based on TikTok research.
She also doesn't mention that compounded semaglutide is not FDA-approved, has no verified bioequivalence data to Wegovy or Ozempic, and carries real quality-control variability depending on the pharmacy. The FDA has flagged this repeatedly.
What should you actually know?
The flexibility of compounded semaglutide dosing is real, but it cuts both ways. Yes, a compound pharmacy can prepare 0.4 mg or 0.6 mg doses that don't come in a Novo Nordisk pen. That flexibility can be useful for managing tolerability under clinical supervision. But that same flexibility means there's no standardized manufacturing process, no FDA-verified potency testing, and no phase 3 trial data backing any specific compounded dose.
The FDA issued a safety communication in 2023 warning about compounded semaglutide products, noting reports of dosing errors and adverse events tied partly to unit confusion between mg and mcg. The agency removed semaglutide from its drug shortage list in 2024, which technically makes most compounded versions illegal to sell unless a patient has a documented allergy or clinical need for an alternative formulation.
Slower titration for tolerability is a reasonable clinical approach. Staying at a sub-therapeutic dose indefinitely because you "feel okay" may not serve your long-term health goals. Talk to a licensed prescriber, not just a TikTok comment section.